Clinical Trial Update: Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating neoadjuvant intravesical vaccine therapy for bladder cancer patients undergoing cystectomy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Adenocarcinoma
• Bladder Cancer
• Bladder Squamous Cell Carcinoma
• Bladder Urothelial Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED